VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $9,384,000 | -47.2% | 92,319 | -7.3% | 1.04% | -49.3% |
| Q3 2015 | $17,764,000 | -10.4% | 99,587 | +11.6% | 2.04% | -0.8% |
| Q2 2015 | $19,824,000 | +26.4% | 89,235 | +13.0% | 2.06% | +26.4% |
| Q1 2015 | $15,682,000 | +59.6% | 78,953 | +15.0% | 1.63% | +60.5% |
| Q4 2014 | $9,827,000 | +16.8% | 68,666 | +7.1% | 1.02% | +9.2% |
| Q3 2014 | $8,411,000 | +11.4% | 64,110 | +7.1% | 0.93% | +10.3% |
| Q2 2014 | $7,547,000 | +5.8% | 59,841 | +10.6% | 0.84% | +1.6% |
| Q1 2014 | $7,135,000 | +47.4% | 54,125 | +31.3% | 0.83% | +45.6% |
| Q4 2013 | $4,839,000 | +34.5% | 41,215 | +19.5% | 0.57% | +23.1% |
| Q3 2013 | $3,599,000 | +46.2% | 34,492 | +20.6% | 0.46% | +42.5% |
| Q2 2013 | $2,462,000 | – | 28,603 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |